Palantir Technologies (NYSE: PLTR) rallied on Monday, snapping a six-day losing streak. The data analytics company has outperformed the S&P 500 significantly over the past year, gaining 141%. Despite a string of red sessions in April, the stock remains a Buy according to Seeking Alpha analysts. Five out of 19 Wall Street analysts rate PLTR as a Buy.
CustomerInsights.AI (CIAI), a provider of technology-enabled solutions for Life Sciences companies, has partnered with Ambit, a consulting firm specializing in rare and specialty diseases.
This partnership combines CIAI’s scalable data architecture, automated workflows, and AI capabilities with Ambit’s consulting expertise in rare diseases. Together, they aim to accelerate the development and deployment of data and analytics solutions for rare and specialty disease companies.
